Table 1.
Baseline characteristics of the 18 included studies.
| Article | Region | Type of study | Follow-up | Age | n Female | Years studied | n patients | n stroke | Outcomes | MINORS |
|---|---|---|---|---|---|---|---|---|---|---|
| Atzmon et al. 201810 | Israel | Retrospective cohort | 9 years | 79.3 | NS | 2003–2014 | 2195 | 110 | Incidence, hypertension, diabetes, atrial fibrillation, renal insufficiency, gender | 16 |
| Goh et al. 202011 | UK | Prospective cohort | 120 days | ≥ 60 | NS | 2020 | 8673 | 52 | Incidence | 19 |
| Griffin et al. 201512 | UK | Retrospective cohort | 1 year | 83.1 | 503 (67.9%) | 2011 | 741 | 1 | Incidence | 20 |
| Hansson et al. 201513 | Sweden | Retrospective cohort | 1 year | 84.0 | 482 (72.6%) | 2011 | 664 | 11 | Incidence | 17 |
| He et al. 202218 | China | Retrospective cohort | 90 days | 79.2 | 1295 (51.5%) | 2017–2020 | 2517 | 63 | Incidence , hypertension, diabetes, atrial fibrillation, heart disease, BMI, gender, albumin | 19 |
| Kang et al. 201119 | Taiwan | Case control in cohort | 1 year | 63.9 | 918 (43.7%) | 2001–2004 | 2101 | 86 | Incidence | 18 |
| Lawrence et al. 202220 | USA | Retrospective cohort | 12 years | 80.2 | 7088 (79.4%) | 1982–1993 | 8930 | 85 | Incidence | 15 |
| Lowe et al. 202021 | USA | Retrospective cohort | 7 years | 73.3 | 11,962 (66.3%) | 2010–2017 | 18,042 | 3181 | Incidence | 17 |
| de Luise et al. 200717 | USA | Retrospective cohort | 6 years | 80.0 | 8561 (71.4%) | 1998–2003 | 11,985 | 2084 | Incidence | 16 |
| Nho et al. 201422 | South Korea | Retrospective cohort | 1 year | – | 408 (74.5%) | – | 548 | 77 | Incidence, gender | 12 |
| Pedersen et al. 201723 | Denmark | Retrospective cohort | 1 year | ≥ 55 | 77,770 (70.3%) | 2015 | 110,563 | 16,787 | Incidence | 21 |
| Popa et al. 200924 | USA | Retrospective cohort | 1 year | 80.8 | 492 (26.1%) | 1988–2002 | 1886 | 76 | Incidence | 19 |
| Ramnemark et al. 201525 | Sweden | Retrospective cohort | 5 years | ≥ 65 | 388 (68.3%) | 1980–1997 | 568 | 67 | Hypertension, diabetes, heart disease, gender | 15 |
| Roche et al. 200526 | UK | Retrospective cohort | 1 year | 82 | 1955 (79.9%) | 1999–2003 | 2448 | 322 | Incidence | 16 |
| Rosencher et al. 200527 | France | Prospective cohort | Inpatient | 82 | 5183 (75.6%) | 2002 | 6860 | 48 | Incidence | 19 |
| Samuel et al. 201728 | USA | Retrospective cohort | Inpatient | ≥ 65 | NS | 2011–2012 | 49,931 | 221 | Incidence | 18 |
| Tsai et al. 20155 | Taiwan | Retrospective cohort | 12 y | 72.4 | 16,920 (71.1%) | 1996–2011 | 23,802 | 2411 | Incidence | 18 |
| Yu et al. 202029 | China | Retrospective cohort | 1 year | 80.0 | 2151 (57.5%) | 2014 | 3743 | 56 | Hypertension, diabetes, heart disease, renal, insufficiency, BMI, gender, albumin | 20 |